InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
14
T+90 hit rate
33%
T+90 mean return
-1.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Peltz Stuart Walter, Chief Executive Officer. Insider active across 1 company, notably PTC Therapeutics, INC.. Aggregated, 17 disclosures have been logged. Split: 0 buy · 14 sells. Total volume traded: €560k. Activity tracked since 11 June 2021. The latest transaction was filed on 31 January 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations17 total
2,320 shares@ US$45.62817.4% of flowCommon StockSEC:0001415889-23-001803:0
284 shares@ US$47.45132.2% of flowCommon StockSEC:0001415889-23-001461:0
1,228 shares@ US$42.93298.8% of flowCommon StockSEC:0001415889-23-000877:0
1,786 shares@ US$41.656212.5% of flowCommon StockSEC:0001415889-23-000834:0
53,000 shares0Common StockSEC:0001415889-23-000688:0
407 shares@ US$26.8280.0002% mcap3.1% of flowCommon StockSEC:0001415889-22-006356:0
82 shares@ US$45.2790.0001% mcap1.0% of flowCommon StockSEC:0001415889-22-004083:0
1,961 shares@ US$40.0020.0011% mcap21.1% of flowCommon StockSEC:0001179110-22-000840:0
1,961 shares@ US$40.00212.5% of flowCommon StockSEC:0001179110-22-000840
330 shares@ US$39.3140.0002% mcap3.5% of flowCommon StockSEC:0001179110-22-000631:0
330 shares@ US$39.3142.0% of flowCommon StockSEC:0001179110-22-000631
1,869 shares@ US$38.5250.0010% mcap19.2% of flowCommon StockSEC:0001179110-22-000394:0
1,869 shares@ US$38.52511.4% of flowCommon StockSEC:0001179110-22-000394
378 shares@ US$41.1622.5% of flowCommon StockSEC:0001179110-22-000299
378 shares@ US$41.1620.0002% mcap4.2% of flowCommon StockSEC:0001179110-22-000299:0
6,240 shares0Common StockSEC:0001179110-21-006621
6,240 shares0Common StockSEC:0001179110-21-006621:0
17 of 17 declarations
About Peltz Stuart Walter
Stuart Walter Peltz is the Chief Executive Officer of PTC THERAPEUTICS, INC. In this role, he oversees the company's operations and research initiatives. His expertise in biotechnology is essential for guiding the development of new therapies. As CEO, he plays a key role in the overall strategy and direction of the company.
